<DOC>
	<DOCNO>NCT01777451</DOCNO>
	<brief_summary>Whole body MRI perform patient neurofibromatosis Type 1 PURPOSE 1 : To determine total tumor load ( neurofibroma ) diagnose plexiform neurofibroma malignant peripheral nerve sheath tumor . All patient scan two year baseline whole body MRI investigate investigate change total tumor load . PURPOSE 2 : add value diffusion weight imaging diagnosis high-risk neurofibroma PURPOSE 3 : determine apparent diffusion coefficient malignant nerve sheath tumor neurofibroma . PURPOSE 4 : correlation histopathology surgically resect neurofibroma/malignant nerve sheath tumor MRI finding</brief_summary>
	<brief_title>Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role Neurofibromatosis</brief_title>
	<detailed_description />
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Nerve Sheath Neoplasms</mesh_term>
	<mesh_term>Neurilemmoma</mesh_term>
	<mesh_term>Neurofibrosarcoma</mesh_term>
	<criteria>Patients neurofibromatosis type 1 , 6 50 year old Patients allow scan MRI ( contraindication : pacemaker ed . )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Whole Body Imaging</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Neurofibromatosis 1</keyword>
	<keyword>Diffusion Magnetic Resonance Imaging</keyword>
	<keyword>Peripheral Nerve Sheath Tumors , Malignant</keyword>
</DOC>